{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T17:18:32Z","timestamp":1763140712755},"reference-count":35,"publisher":"Elsevier BV","issue":"33","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,9]],"date-time":"2020-09-09T00:00:00Z","timestamp":1599609600000},"content-version":"vor","delay-in-days":2231,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1074\/jbc.m113.492934","type":"journal-article","created":{"date-parts":[[2014,6,28]],"date-time":"2014-06-28T02:43:14Z","timestamp":1403923394000},"page":"23123-23131","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["A Coding IRAK2 Protein Variant Compromises Toll-like receptor (TLR) Signaling and Is Associated with Colorectal Cancer Survival"],"prefix":"10.1016","volume":"289","author":[{"given":"Hui","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sinead M.","family":"Flannery","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabine","family":"Dickh\u00f6fer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefanie","family":"Huhn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"George","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andriy V.","family":"Kubarenko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jesus","family":"Lascorz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melanie","family":"Bevier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joschka","family":"Willemsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tica","family":"Pichulik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clemens","family":"Schafmayer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Binder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B\u00e9n\u00e9dicte","family":"Manoury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00f8ren R.","family":"Paludan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Alarcon-Riquelme","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew G.","family":"Bowie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asta","family":"F\u00f6rsti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander N.R.","family":"Weber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1074\/jbc.M113.492934_bib1","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.immuni.2011.05.006","article-title":"Toll-like receptors and their crosstalk with other innate receptors in infection and immunity","volume":"34","author":"Kawai","year":"2011","journal-title":"Immunity"},{"key":"10.1074\/jbc.M113.492934_bib2","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/ni1112","article-title":"Toll-like receptor control of the adaptive immune responses","volume":"5","author":"Iwasaki","year":"2004","journal-title":"Nat. Immunol"},{"key":"10.1074\/jbc.M113.492934_bib3","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1600-065X.2008.00701.x","article-title":"The interleukin-1 receptor\/Toll-like receptor superfamily: 10 years of progress","volume":"226","author":"O'Neill","year":"2008","journal-title":"Immunol. Rev"},{"key":"10.1074\/jbc.M113.492934_bib4","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1016\/j.bcp.2010.06.020","article-title":"The interleukin-1 receptor-associated kinases: critical regulators of innate immune signalling","volume":"80","author":"Flannery","year":"2010","journal-title":"Biochem. Pharmacol"},{"key":"10.1074\/jbc.M113.492934_bib5","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/MD.0b013e3181fd8ec3","article-title":"Clinical features and outcome of patients with IRAK-4 and MyD88 deficiency","volume":"89","author":"Picard","year":"2010","journal-title":"Medicine"},{"key":"10.1074\/jbc.M113.492934_bib6","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nature09671","article-title":"Oncogenically active MYD88 mutations in human lymphoma","volume":"470","author":"Ngo","year":"2011","journal-title":"Nature"},{"key":"10.1074\/jbc.M113.492934_bib7","doi-asserted-by":"crossref","first-page":"25404","DOI":"10.1074\/jbc.M109.022392","article-title":"An oligomeric signalling platform formed by the Toll-like receptor signal transducers MyD88 and IRAK4","volume":"284","author":"Motshwene","year":"2009","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M113.492934_bib8","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/nature09121","article-title":"Helical assembly in the MyD88-IRAK4-IRAK2 complex in TLR\/IL-1R signalling","volume":"465","author":"Lin","year":"2010","journal-title":"Nature"},{"key":"10.1074\/jbc.M113.492934_bib9","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1074\/jbc.M110.159996","article-title":"Two human MYD88 variants, S34Y and R98C, interfere with MyD88-IRAK4-Myddosome assembly","volume":"286","author":"George","year":"2011","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M113.492934_bib10","doi-asserted-by":"crossref","first-page":"23688","DOI":"10.1074\/jbc.M111.248351","article-title":"Human interleukin-1 receptor-associated kinase-2 is essential for Toll-like receptor-mediated transcriptional and post-transcriptional regulation of tumor necrosis factor \u03b1","volume":"286","author":"Flannery","year":"2011","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M113.492934_bib11","doi-asserted-by":"crossref","first-page":"19403","DOI":"10.1074\/jbc.274.27.19403","article-title":"IRAK-M is a novel member of the Pelle\/interleukin-1 receptor-associated kinase (IRAK) family","volume":"274","author":"Wesche","year":"1999","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M113.492934_bib12","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/ni.1606","article-title":"Sequential control of Toll-like receptor-dependent responses by IRAK1 and IRAK2","volume":"9","author":"Kawagoe","year":"2008","journal-title":"Nat. Immunol"},{"key":"10.1074\/jbc.M113.492934_bib13","doi-asserted-by":"crossref","first-page":"11875","DOI":"10.1074\/jbc.M110.199653","article-title":"Natural loss-of-function mutation of myeloid differentiation protein 88 disrupts its ability to form Myddosomes","volume":"286","author":"Nagpal","year":"2011","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M113.492934_bib14","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/nature02168","article-title":"The International HapMap Project","volume":"426","author":"International HapMap Consortium","year":"2003","journal-title":"Nature"},{"key":"10.1074\/jbc.M113.492934_bib15","doi-asserted-by":"crossref","first-page":"33435","DOI":"10.1074\/jbc.M705266200","article-title":"IRAK-2 participates in multiple Toll-like receptor signaling pathways to NF\u03baB via activation of TRAF6 ubiquitination","volume":"282","author":"Keating","year":"2007","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M113.492934_bib16","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1002\/pro.5560030923","article-title":"Derivation of rules for comparative protein modeling from a database of protein structure alignments","volume":"3","author":"Sali","year":"1994","journal-title":"Protein Sci"},{"key":"10.1074\/jbc.M113.492934_bib17","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/j.str.2006.11.001","article-title":"Crystal structures of IRAK-4 kinase in complex with inhibitors: a serine\/threonine kinase with tyrosine as a gatekeeper","volume":"14","author":"Wang","year":"2006","journal-title":"Structure"},{"key":"10.1074\/jbc.M113.492934_bib18","doi-asserted-by":"crossref","first-page":"3404","DOI":"10.1002\/art.27677","article-title":"A 3\u2032-untranslated region variant is associated with impaired expression of CD226 in T and natural killer T cells and is associated with susceptibility to systemic lupus erythematosus","volume":"62","author":"L\u00f6fgren","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1074\/jbc.M113.492934_bib19","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/j.ejca.2010.12.011","article-title":"TLR-3 polymorphism is an independent prognostic marker for stage II colorectal cancer","volume":"47","author":"Castro","year":"2011","journal-title":"Eur. J. Cancer"},{"key":"10.1074\/jbc.M113.492934_bib20","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1126\/science.278.5343.1612","article-title":"IRAK (Pelle) family member IRAK-2 and MyD88 as proximal mediators of IL-1 signaling","volume":"278","author":"Muzio","year":"1997","journal-title":"Science"},{"key":"10.1074\/jbc.M113.492934_bib21","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.it.2010.12.005","article-title":"What the Myddosome structure tells us about the initiation of innate immunity","volume":"32","author":"Gay","year":"2011","journal-title":"Trends Immunol"},{"key":"10.1074\/jbc.M113.492934_bib22","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0092-8674(02)00827-9","article-title":"IRAK-M is a negative regulator of Toll-like receptor signaling","volume":"110","author":"Kobayashi","year":"2002","journal-title":"Cell"},{"key":"10.1074\/jbc.M113.492934_bib23","doi-asserted-by":"crossref","first-page":"25742","DOI":"10.1074\/jbc.M109.014886","article-title":"A TIR domain variant of MyD88 adapter-like (Mal)\/TIRAP results in loss of MyD88 binding and reduced TLR2\/TLR4 signaling","volume":"284","author":"Nagpal","year":"2009","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M113.492934_bib24","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.4049\/jimmunol.1203268","article-title":"Two phases of inflammatory mediator production defined by the study of IRAK2 and IRAK1 knock-in mice","volume":"191","author":"Pauls","year":"2013","journal-title":"J. Immunol"},{"key":"10.1074\/jbc.M113.492934_bib25","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1084\/jem.20090490","article-title":"A mutation in Irak2c identifies IRAK-2 as a central component of the TLR regulatory network of wild-derived mice","volume":"206","author":"Conner","year":"2009","journal-title":"J. Exp. Med"},{"key":"10.1074\/jbc.M113.492934_bib26","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/sj.onc.1210912","article-title":"Polymorphisms in Toll-like receptor genes and risk of cancer","volume":"27","author":"El-Omar","year":"2008","journal-title":"Oncogene"},{"key":"10.1074\/jbc.M113.492934_bib27","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1600-065X.2008.00630.x","article-title":"Development of TLR inhibitors for the treatment of autoimmune diseases","volume":"223","author":"Barrat","year":"2008","journal-title":"Immunol. Rev"},{"key":"10.1074\/jbc.M113.492934_bib28","doi-asserted-by":"crossref","first-page":"41661","DOI":"10.1074\/jbc.M102262200","article-title":"IRAK-mediated translocation of TRAF6 and TAB2 in the interleukin-1-induced activation of NF\u03baB","volume":"276","author":"Qian","year":"2001","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M113.492934_bib29","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1128\/MCB.02380-06","article-title":"Interleukin-1 (IL-1) induces the Lys63-linked polyubiquitination of IL-1 receptor-associated kinase 1 to facilitate NEMO binding and the activation of IkappaBalpha kinase","volume":"28","author":"Windheim","year":"2008","journal-title":"Mol. Cell. Biol"},{"key":"10.1074\/jbc.M113.492934_bib30","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1126\/science.1158298","article-title":"Pyogenic bacterial infections in humans with MyD88 deficiency","volume":"321","author":"von Bernuth","year":"2008","journal-title":"Science"},{"key":"10.1074\/jbc.M113.492934_bib31","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.gde.2009.04.010","article-title":"Common vs. rare allele hypotheses for complex diseases","volume":"19","author":"Schork","year":"2009","journal-title":"Curr. Opin. Genet. Dev"},{"key":"10.1074\/jbc.M113.492934_bib32","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/ng1976","article-title":"A Mal functional variant is associated with protection against invasive pneumococcal disease, bacteremia, malaria and tuberculosis","volume":"39","author":"Khor","year":"2007","journal-title":"Nat. Genet"},{"key":"10.1074\/jbc.M113.492934_bib33","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.7150\/ijbs.4614","article-title":"Interleukin-6: a key regulator of colorectal cancer development","volume":"8","author":"Waldner","year":"2012","journal-title":"Int. J. Biol. Sci"},{"key":"10.1074\/jbc.M113.492934_bib34","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","article-title":"Global cancer statistics","volume":"61","author":"Jemal","year":"2011","journal-title":"CA Cancer J. Clin"},{"key":"10.1074\/jbc.M113.492934_bib35","doi-asserted-by":"crossref","first-page":"724","DOI":"10.2174\/156802609789044407","article-title":"IRAK-4 inhibitors for inflammation","volume":"9","author":"Wang","year":"2009","journal-title":"Curr. Top. Med. Chem"}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820331094?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820331094?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1074\/jbc.M113.492934","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,12]],"date-time":"2024-04-12T20:20:11Z","timestamp":1712953211000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925820331094"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":35,"journal-issue":{"issue":"33","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S0021925820331094"],"URL":"https:\/\/doi.org\/10.1074\/jbc.m113.492934","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Coding IRAK2 Protein Variant Compromises Toll-like receptor (TLR) Signaling and Is Associated with Colorectal Cancer Survival","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1074\/jbc.M113.492934","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2014 ASBMB. Currently published by Elsevier Inc; originally published by American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}]}}